| AGEPX | MEDFX | AGEPX / MEDFX | |
| Total Expense Ratio | 1.33 | 1.07 | 124% |
| Annual Report Gross Expense Ratio | 1.33 | 1.08 | 123% |
| Fund Existence | 13 years | 18 years | - |
| Gain YTD | 9.543 | 1.602 | 596% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.96B | 7.5B | 26% |
| Annual Yield % from dividends | 9.60 | 5.33 | 180% |
| Returns for 1 year | 16.79 | 5.12 | 328% |
| Returns for 3 years | 58.26 | 30.89 | 189% |
| Returns for 5 years | 47.03 | 10.97 | 429% |
| Returns for 10 years | 106.24 | 37.49 | 283% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PSYGX | 96.23 | 1.19 | +1.25% |
| Putnam Small Cap Growth Y | |||
| VGIAX | 121.54 | 0.95 | +0.79% |
| Vanguard Growth & Income Adm | |||
| TSPTX | 5.47 | 0.04 | +0.74% |
| Transamerica Small Cap Growth I3 | |||
| BRUEX | 19.34 | 0.14 | +0.73% |
| MFS Blended Research Value Equity B | |||
| PEQUX | 21.47 | 0.13 | +0.61% |
| Putnam Focused International Equity A | |||